Role of endothelin-1 in a cirrhotic rat model with endotoxin induced acute renal failure

被引:13
作者
Özdogan, O
Gören, MZ
Ratip, S
Giral, A
Moini, H
Enç, F
Birsel, S
Berkman, K
Tözün, N
机构
[1] Marmara Univ, Sch Med, Dept Gastroenterol, TR-81190 Istanbul, Turkey
[2] Marmara Univ, Sch Med, Dept Pharmacol & Clin Pharmacol, TR-81190 Istanbul, Turkey
[3] Marmara Univ, Sch Med, Dept Internal Med, TR-81190 Istanbul, Turkey
[4] Marmara Univ, Sch Med, Dept Biochem, TR-81190 Istanbul, Turkey
关键词
endothelin-1; bosentan; cirrhosis; hepatorenal syndrome; nitric oxide;
D O I
10.1016/S1386-6346(02)00082-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/aims: Bacterial infections are known to trigger renal failure in patients with cirrhosis. However, the mechanisms for this process are unclear. The aim of this study was to investigate the role of endothelin-1 (ET-1) in a cirrhotic rat model with endotoxin induced renal failure by mixed ET-1 receptor antagonist, bosentan. Methods: Cirrrhosis was induced by twice weekly intraperitoneal injections of CCl4 together with phenobarbital in drinking water. Cirrhotic and non-cirrhotic rats were either pretreated with physiological saline or bosentan prior to administration of low dose endotoxin. Urine and blood samples were then collected within a period of 3 h for the estimation of ET-1, NO3-/NO2- levels ( nitric oxide metabolites: NOx) and renal function tests. Results: Cirrhotic rats had higher ET-1 and NO, levels in comparison with non-cirrhotic rats. Endotoxin administration to cirrhotic rats led to the deterioration of the renal function, and elevation of plasma ET-1 and NO, levels. Bosentan pretreatment prior to endotoxin administration caused an increase in the urine volume and creatinine clearance of cirrhotic rats, but had no effect on Na+ excretion. Conclusion: ET-1 has a significant role in endotoxin induced renal impairment in cirrhotic rats, and ET-1 receptor antagonism provides partial protection of the renal function. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:114 / 124
页数:11
相关论文
共 46 条
  • [21] HOCHER B, 1995, J CARDIOVASC PHARM, V26, pS434
  • [22] Endothelins: Renal tubule synthesis and actions
    Kohan, DE
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1996, 23 (04) : 337 - 344
  • [23] MECHANISMS OF DISEASE - ENDOTHELINS
    LEVIN, ER
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (06) : 356 - 363
  • [24] LUMBSDEN AB, 1986, HEPATOLOGY, V8, P232
  • [25] Mechanisms of disease -: Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis
    Martin, PY
    Ginès, P
    Schrier, RW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (08) : 533 - 541
  • [26] MASUMOTO H, 1994, DIGEST DIS SCI, V39, P2665
  • [27] PLASMA ENDOTHELIN IMMUNOREACTIVITY IN LIVER-DISEASE AND THE HEPATORENAL-SYNDROME
    MOORE, K
    WENDON, J
    FRAZER, M
    KARANI, J
    WILLIAMS, R
    BADR, K
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (25) : 1774 - 1778
  • [28] MORISE Z, 1994, SURGERY, V115, P199
  • [29] NINOMIYA H, 1991, EUR J PHARMACOL, V203, P299
  • [30] A time-dependent balance between endothelins and nitric oxide regulating portal resistance after endotoxin
    Pannen, BHJ
    Bauer, M
    Zhang, JX
    Robotham, JL
    Clemens, MG
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1996, 271 (05): : H1953 - H1961